ALMS · Alumis Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 6.06 USD |
|---|---|
| 1-day change | -7.6% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 7 / 2 / 83 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 13 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -49.6% |
| Sales growth Q/Q | -6.6% |
| Distance from 52-week high | +80.0% |
| Market cap (USD) | $3.3B |